Price Chart

Profile

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
URL https://www.tevapharm.com
Investor Relations URL https://ir.tevapharm.com/
HQ State/Province N/A
Sector Health Care
Industry Pharmaceuticals
Equity Style Large Cap/Value
Next Earnings Release Nov. 06, 2024
Last Earnings Release Jul. 31, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Nov. 27, 2017

Profile

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
URL https://www.tevapharm.com
Investor Relations URL https://ir.tevapharm.com/
HQ State/Province N/A
Sector Health Care
Industry Pharmaceuticals
Equity Style Large Cap/Value
Next Earnings Release Nov. 06, 2024
Last Earnings Release Jul. 31, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Nov. 27, 2017